To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene COPS4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
463 supporting clones for gene COPS4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR609378 neuroblastoma .a 1 to 1702 1 to 1702 exact tiling clone,   1702/1702
(100 %)
0 diff
(100 %id)
AL519119 brain, neuroblastoma, neuroblastoma cells .a 1 to 856 1 to 855   fully sequenced,   855/855
(100 %)
1 diff
(99.9 %id)
TI_154170397   .a 458 to 1117 80 to 735       656/848
(77 %)
21 diff
(97.6 %id)
AL519118 brain, neuroblastoma, neuroblastoma cells .a 826 to 1702 879 to 2   fully sequenced,   878/879
(99 %)
11 diff
(98.8 %id)
TI_149297848   .a 905 to 1694 865 to 82   AAA   784/966
(81 %)
10 diff
(99.0 %id)
BM982851 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 976 to 1694 737 to 19   AAA   719/719
(100 %)
3 diff
(99.6 %id)
BX442446 brain, fetal brain .b 1 to 976 9 to 977   fully sequenced,   977/977
(100 %)
18 diff
(98.2 %id)
AU310221 neuroblastoma .b 1 to 578 6 to 583   tiling clone,   583/583
(100 %)
0 diff
(100 %id)
N94182 liver and spleen .b 14 to 498 1 to 487       487/488
(99 %)
8 diff
(98.4 %id)
CR625192 Placenta Cot 25-normalized .b 20 to 1714 1 to 1695 exact tiling clone,   1695/1695
(100 %)
0 diff
(100 %id)
AA490731 germinal center B cell .b 34 to 532 1 to 499       499/499
(100 %)
1 diff
(99.8 %id)
BX336713 Placenta Cot 25-normalized .b 746 to 1714 966 to 1       966/969
(99 %)
13 diff
(98.7 %id)
BX435560 brain, fetal brain .b 948 to 1742 800 to 4   fully sequenced,   797/800
(99 %)
24 diff
(97.0 %id)
AU310222 neuroblastoma .b 1192 to 1750 560 to 2       559/560
(99 %)
0 diff
(100 %id)
FN058617 breast carcinoma .b 1219 to 1313 95 to 1     Submitted on the opposite strand 95/95
(100 %)
0 diff
(100 %id)
BE670483 carcinoid, lung .b 1233 to 1775 553 to 11   tiling clone, AAA   543/543
(100 %)
0 diff
(100 %id)
N63824 liver and spleen .b 1257 to 1747 500 to 1       500/516
(96 %)
12 diff
(97.7 %id)
AA491222 germinal center B cell .b 1474 to 1771 308 to 11   AAA   298/298
(100 %)
0 diff
(100 %id)
NM_016129.2   .c 1 to 1742 6 to 1747 exact RefSeq, AAA   1747/1747
(100 %)
0 diff
(100 %id)
AK001148 whole embryo, mainly body .c 1 to 1714 2 to 1715 I330V tiling clone, available from FLJ,   1715/1715
(100 %)
1 diff
(100.0 %id)
CR600458 HeLa cells Cot 25-normalized .c 92 to 1658 1 to 1567 exact     1567/1567
(100 %)
0 diff
(100 %id)
AK024005   .c 111 to 1714 1 to 1604 exact available from FLJ,   1604/1604
(100 %)
0 diff
(100 %id)
BC093007 Placenta, normal .c 111 to 1714 1 to 1604 exact AAA   1604/1604
(100 %)
1 diff
(100.0 %id)
BX461884 brain, fetal brain .c 116 to 795 22 to 699       657/758
(86 %)
11 diff
(98.6 %id)
BX362973   .c 116 to 880 23 to 786   fully sequenced,   764/786
(97 %)
9 diff
(98.9 %id)
AL559986 B cells (Ramos cell line), B cells from Burkitt lymphoma .c 125 to 880 1 to 755   fully sequenced,   755/755
(100 %)
3 diff
(99.7 %id)
AK223178 Pancreas .c 126 to 1641 1 to 1516 E221K     1516/1516
(100 %)
1 diff
(100.0 %id)
CR607122 B cells (Ramos cell line) .c 126 to 1704 1 to 1579 exact     1579/1579
(100 %)
0 diff
(100 %id)
H11867 whole brain .c 130 to 544 1 to 419       419/446
(93 %)
17 diff
(96.2 %id)
AF100757 Pituitary .c 132 to 1714 1 to 1583 A2M AAA   1583/1583
(100 %)
2 diff
(99.9 %id)
BC004302 Pancreas, adenocarcinoma .c 133 to 1714 1 to 1582 exact available from MGC, AAA   1582/1582
(100 %)
0 diff
(100 %id)
BC009292 Muscle, rhabdomyosarcoma .c 133 to 1742 1 to 1610 exact tiling clone, available from MGC, AAA   1610/1610
(100 %)
0 diff
(100 %id)
CR620923 neuroblastoma .c 134 to 1701 1 to 1568 exact     1568/1568
(100 %)
0 diff
(100 %id)
AL515927 brain, neuroblastoma, neuroblastoma cells .c 134 to 950 1 to 814   fully sequenced,   814/814
(100 %)
10 diff
(98.8 %id)
TI_1948126350   .c 135 to 857 134 to 856   fully sequenced,   723/856
(84 %)
10 diff
(98.9 %id)
TI_1948126499   .c 135 to 856 130 to 851       722/1368
(52 %)
17 diff
(98.8 %id)
TI_1948126651   .c 135 to 825 146 to 845       700/1425
(49 %)
40 diff
(97.2 %id)
BM463124 melanotic melanoma, skin .c 138 to 1219 1 to 1070       1072/1070
(100 %)
24 diff
(97.8 %id)
CR620449 neuroblastoma .c 139 to 1682 1 to 1544       1544/1544
(100 %)
0 diff
(100 %id)
BX461618 brain, fetal brain .c 139 to 1206 1 to 1060       1060/1065
(99 %)
10 diff
(99.1 %id)
CR595705 T cells (Jurkat cell line) Cot10-normalized .c 153 to 1678 1 to 1526       1526/1526
(100 %)
0 diff
(100 %id)
AL558592 T cells from T cell leukemia .c 153 to 880 1 to 727   fully sequenced,   727/727
(100 %)
0 diff
(100 %id)
BX437068 thymus .c 156 to 856 23 to 734       710/738
(96 %)
29 diff
(96.1 %id)
H87633 placenta .c 156 to 544 1 to 390       390/399
(97 %)
3 diff
(99.3 %id)
AK001210   .c 169 to 1742 1 to 1574   available from FLJ,   1574/1574
(100 %)
1 diff
(100.0 %id)
R56542 whole brain .c 178 to 612 1 to 442       442/525
(84 %)
20 diff
(96.2 %id)
BX462631 T cells (Jurkat cell line) .c 400 to 1167 1 to 768   fully sequenced,   768/768
(100 %)
3 diff
(99.7 %id)
CR605209 T cells (Jurkat cell line) .c 401 to 1731 1 to 1331       1331/1331
(100 %)
0 diff
(100 %id)
BF204532 muscle, rhabdomyosarcoma .c 437 to 1168 1 to 713       717/774
(92 %)
29 diff
(96.3 %id)
BF307774 muscle, rhabdomyosarcoma .c 437 to 1225 1 to 801       801/859
(93 %)
35 diff
(96.0 %id)
BM553784 amelanotic melanoma, cell line, skin .c 440 to 1217 27 to 808       777/1104
(70 %)
13 diff
(98.9 %id)
BG746993 adenocarcinoma cell line, colon .c 441 to 1295 1 to 849       844/864
(97 %)
22 diff
(97.5 %id)
BM916604 amelanotic melanoma, cell line, skin .c 442 to 1396 1 to 964       964/1120
(86 %)
41 diff
(96.4 %id)
BU528110 epidermoid carcinoma, cell line, lung .c 456 to 1323 1 to 882       882/894
(98 %)
33 diff
(96.4 %id)
BE896969 melanotic melanoma, skin .c 458 to 1198 1 to 742       742/745
(99 %)
8 diff
(99.0 %id)
CR600599 adult brain .c 507 to 1695 1 to 1189       1189/1189
(100 %)
0 diff
(100 %id)
BX444605 adult brain, brain .c 507 to 880 1 to 374   fully sequenced,   374/374
(100 %)
0 diff
(100 %id)
BG290783 bladder, transitional cell papilloma, cell line .c 520 to 1192 1 to 675       673/1061
(63 %)
9 diff
(99.2 %id)
BG183635   .c 541 to 1316 1 to 775       775/776
(99 %)
8 diff
(99.0 %id)
BX106366 uterus .c 563 to 1314 1 to 753       753/753
(100 %)
1 diff
(99.9 %id)
BX464801 neuroblastoma .c 576 to 1682 1100 to 1       1100/1126
(97 %)
16 diff
(98.6 %id)
BG217513   .c 587 to 1221 1 to 634       634/681
(93 %)
24 diff
(96.5 %id)
BG621821 placenta .c 617 to 1417 1 to 802       802/803
(99 %)
11 diff
(98.7 %id)
BG739730 skin .c 625 to 1406 1 to 777       777/778
(99 %)
11 diff
(98.6 %id)
DT217398 brain .c 648 to 1290 1 to 643       643/643
(100 %)
0 diff
(100 %id)
BF982717 duodenal adenocarcinoma, cell line, small intestine .c 680 to 1485 11 to 820       810/993
(81 %)
33 diff
(96.7 %id)
BQ927007 brain, neuroblastoma, cell line .c 697 to 1597 35 to 945       911/945
(96 %)
20 diff
(97.9 %id)
BM310812 Pancreas, Purified pancreatic islet .c 698 to 1144 8 to 455       448/455
(98 %)
7 diff
(98.5 %id)
BG340002 leiomyosarcoma cell line, uterus .c 728 to 1506 1 to 779       779/780
(99 %)
6 diff
(99.3 %id)
BQ068750 brain, neuroblastoma, cell line .c 728 to 1587 1 to 873       873/921
(94 %)
20 diff
(97.9 %id)
BQ890165 brain, neuroblastoma, cell line .c 729 to 1627 1 to 900       900/900
(100 %)
9 diff
(99.0 %id)
T79686 liver and spleen .c 744 to 1063 1 to 330       330/330
(100 %)
15 diff
(95.5 %id)
BM718990 eye, fetal eye .c 748 to 1194 1 to 447   fully sequenced,   447/447
(100 %)
0 diff
(100 %id)
BQ674119 epidermoid carcinoma, cell line, salivary gland .c 751 to 1605 23 to 899       877/1033
(84 %)
32 diff
(97.0 %id)
BQ672758 epidermoid carcinoma, cell line, salivary gland .c 753 to 1627 1 to 875       875/914
(95 %)
30 diff
(96.8 %id)
BF686013 leiomyosarcoma cell line, uterus .c 761 to 1547 1 to 776       776/926
(83 %)
15 diff
(98.4 %id)
BF685092 leiomyosarcoma cell line, uterus .c 761 to 1521 1 to 754       754/868
(86 %)
21 diff
(97.6 %id)
BF972480 leiomyosarcoma cell line, uterus .c 761 to 1617 1 to 851       851/989
(86 %)
22 diff
(97.8 %id)
BG340410 leiomyosarcoma cell line, uterus .c 761 to 1604 1 to 840       840/1125
(74 %)
16 diff
(98.6 %id)
AA252568 germinal center B cell .c 776 to 1271 1 to 493       493/493
(100 %)
3 diff
(99.4 %id)
AA259003 germinal center B cell .c 776 to 1318 1 to 538       538/541
(99 %)
7 diff
(98.8 %id)
CN363172 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 787 to 1390 1 to 604       604/604
(100 %)
0 diff
(100 %id)
N55122 multiple sclerosis lesions .c 793 to 1167 1 to 375       375/375
(100 %)
3 diff
(99.2 %id)
CB051823 leiomyosarcoma, soft tissue .c 796 to 924 1 to 129       129/129
(100 %)
2 diff
(98.5 %id)
BE743967 adenocarcinoma cell line, ovary .c 805 to 1502 1 to 697       697/697
(100 %)
1 diff
(99.9 %id)
CK004769 brain/CNS, Human Brain - Frontal Cortex .c 815 to 1481 1 to 666       666/666
(100 %)
6 diff
(99.1 %id)
DA727600   .c 818 to 1485 2 to 690   capped   689/695
(99 %)
24 diff
(96.6 %id)
AL581505 B cells (Ramos cell line), B cells from Burkitt lymphoma .c 819 to 1704 884 to 1   fully sequenced,   884/884
(100 %)
6 diff
(99.4 %id)
AL580374 T cells from T cell leukemia .c 819 to 1678 858 to 1   fully sequenced,   858/858
(100 %)
8 diff
(99.1 %id)
BX362972   .c 819 to 1658 841 to 1   fully sequenced,   841/841
(100 %)
0 diff
(100 %id)
BX444604 adult brain, brain .c 819 to 1696 876 to 1   fully sequenced,   876/876
(100 %)
1 diff
(99.9 %id)
TI_1948126351   .c 819 to 1354 680 to 136   fully sequenced,   545/680
(80 %)
12 diff
(98.3 %id)
CD513828 brain, Pituitary .c 848 to 1714 39 to 906   AAA   868/906
(95 %)
10 diff
(98.9 %id)
TI_1948126500   .c 848 to 1354 648 to 140       509/1302
(39 %)
7 diff
(99.5 %id)
TI_1948126652   .c 848 to 1361 642 to 127       516/1423
(36 %)
32 diff
(97.8 %id)
BX437067 thymus .c 850 to 1694 849 to 1       849/849
(100 %)
15 diff
(98.3 %id)
BX413792 brain, fetal brain .c 858 to 1721 868 to 8       861/868
(99 %)
8 diff
(99.1 %id)
BX352148 Placenta Cot 25-normalized .c 872 to 1713 842 to 1     Submitted on the opposite strand 840/857
(98 %)
22 diff
(97.5 %id)
AI745197 pooled .c 906 to 1714 825 to 18   AAA   806/808
(99 %)
23 diff
(97.2 %id)
TI_154052511   .c 914 to 1738 902 to 84   AAA   819/956
(85 %)
17 diff
(98.3 %id)
AL515926 brain, neuroblastoma, neuroblastoma cells .c 920 to 1701 783 to 1   fully sequenced,   783/783
(100 %)
14 diff
(98.3 %id)
AI307263 2 pooled tumors (clear cell type), Kidney .c 921 to 1714 805 to 11   AAA   795/795
(100 %)
13 diff
(98.4 %id)
AI341699   .c 930 to 1722 792 to 2       791/792
(99 %)
8 diff
(99.0 %id)
EL953668 eyeball .c 938 to 1569 20 to 652       633/652
(97 %)
6 diff
(99.1 %id)
TI_149310974   .c 940 to 1714 865 to 97   AAA   769/875
(87 %)
12 diff
(98.7 %id)
N42229 placenta .c 945 to 1235 1 to 291       291/291
(100 %)
4 diff
(98.7 %id)
TI_149306013   .c 946 to 1714 843 to 86   AAA   758/882
(85 %)
14 diff
(98.5 %id)
TI_151795784   .c 955 to 1582 112 to 739       628/628
(100 %)
7 diff
(98.9 %id)
BF803135 colon_ins .c 962 to 1356 37 to 431       395/431
(91 %)
6 diff
(98.7 %id)
BE259300 eye, retinoblastoma .c 965 to 1324 1 to 360       360/363
(99 %)
1 diff
(99.8 %id)
CA413678 Chondrosarcoma Grade II, Left Pelvis .c 1009 to 1714 724 to 19   AAA   706/706
(100 %)
2 diff
(99.8 %id)
BU621429 cell lines, Chondrosarcoma .c 1009 to 1714 723 to 19   AAA   705/705
(100 %)
3 diff
(99.6 %id)
BG120521 adenocarcinoma, cell line, Liver .c 1014 to 1737 13 to 734   AAA   722/734
(98 %)
6 diff
(99.2 %id)
AW024453 Kidney .c 1020 to 1714 694 to 1       694/772
(89 %)
4 diff
(99.5 %id)
TI_149278384   .c 1020 to 1714 792 to 99   AAA   694/1040
(66 %)
1 diff
(100.0 %id)
BU753462 placenta .c 1021 to 1714 708 to 18   AAA   691/700
(98 %)
5 diff
(99.3 %id)
BF223001 pooled germ cell tumors .c 1026 to 1717 695 to 1       695/695
(100 %)
7 diff
(99.0 %id)
AI858424 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1030 to 1390 360 to 1       360/365
(98 %)
14 diff
(96.2 %id)
BF056166 pooled .c 1035 to 1714 690 to 14   AAA   677/677
(100 %)
7 diff
(99.0 %id)
AI768396 pooled .c 1053 to 1708 657 to 1       657/657
(100 %)
9 diff
(98.7 %id)
BP356591 mammary gland .c 1062 to 1509 1 to 448       448/451
(99 %)
4 diff
(99.2 %id)
CA444514 Fibrosarcoma .c 1063 to 1714 671 to 19   AAA   653/653
(100 %)
3 diff
(99.6 %id)
BU678457 lung .c 1065 to 1714 668 to 19   AAA   650/650
(100 %)
0 diff
(100 %id)
BG105367 adrenal cortex carcinoma, cell line, adrenal gland .c 1072 to 1713 1 to 640   AAA   640/640
(100 %)
6 diff
(99.1 %id)
AI372498   .c 1079 to 1487 414 to 1       414/414
(100 %)
6 diff
(98.6 %id)
BE045566 carcinoid, lung .c 1089 to 1714 651 to 26   AAA   626/626
(100 %)
14 diff
(97.8 %id)
AI814769 adenocarcinoma, Pancreas .c 1092 to 1390 299 to 1       299/299
(100 %)
8 diff
(97.4 %id)
AI972852 Prostate .c 1094 to 1711 619 to 1       619/647
(95 %)
9 diff
(98.7 %id)
AI421004 Prostate .c 1095 to 1714 620 to 1       620/620
(100 %)
3 diff
(99.6 %id)
CA429075 Cell Line, Chondrosarcoma .c 1096 to 1714 638 to 19   AAA   620/620
(100 %)
2 diff
(99.7 %id)
W92624 heart .c 1097 to 1440 1 to 344   fully sequenced,   344/344
(100 %)
2 diff
(99.5 %id)
BF965212 muscle (skeletal) .c 1098 to 1743 1 to 651   tiling clone,   651/771
(84 %)
6 diff
(99.3 %id)
BU634187 cell lines, Chondrosarcoma .c 1100 to 1714 634 to 19   AAA   616/616
(100 %)
2 diff
(99.7 %id)
CA429670 Cell Line, Chondrosarcoma .c 1104 to 1714 630 to 19   AAA   612/612
(100 %)
1 diff
(99.9 %id)
BX436053 T cells (Jurkat cell line) .c 1106 to 1721 621 to 8   fully sequenced,   614/621
(98 %)
0 diff
(100 %id)
BU689137 lung .c 1108 to 1714 626 to 19   AAA   608/608
(100 %)
1 diff
(99.9 %id)
BG141371 Islets of Langerhans, Pancreas .c 1109 to 1352 1 to 244       244/244
(100 %)
11 diff
(95.5 %id)
H98500 melanocyte .c 1111 to 1443 15 to 351   fully sequenced,   337/351
(96 %)
6 diff
(98.3 %id)
BU686193 lung, Primary Lung Epithelial Cells .c 1112 to 1714 622 to 19   AAA   604/604
(100 %)
1 diff
(99.9 %id)
BQ446512 Knee, Osteoarthritic Cartilage .c 1112 to 1714 622 to 19   AAA   604/604
(100 %)
2 diff
(99.7 %id)
BE843432 testis_normal .c 1113 to 1531 419 to 1       419/419
(100 %)
18 diff
(95.8 %id)
AI131562 heart .c 1116 to 1714 615 to 17   AAA   599/599
(100 %)
3 diff
(99.5 %id)
DB277385 uterus .c 1116 to 1654 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
BM310503 Pancreas, Purified pancreatic islet .c 1122 to 1722 603 to 2       602/603
(99 %)
0 diff
(100 %id)
AI769539 2 pooled tumors (clear cell type), Kidney .c 1126 to 1714 604 to 15   AAA   590/624
(94 %)
10 diff
(98.4 %id)
EL945751 eyeball .c 1131 to 1572 1 to 442       442/442
(100 %)
1 diff
(99.8 %id)
BG220479   .c 1138 to 1688 557 to 7     Submitted on the opposite strand 551/558
(98 %)
8 diff
(98.6 %id)
BM313451 Pancreas, Purified pancreatic islet .c 1140 to 1742 613 to 11   AAA   603/603
(100 %)
0 diff
(100 %id)
AA773252 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1140 to 1500 1 to 361       361/361
(100 %)
7 diff
(98.1 %id)
CB051822 leiomyosarcoma, soft tissue .c 1141 to 1742 637 to 36   AAA   602/602
(100 %)
0 diff
(100 %id)
BE245398 leukopheresis .c 1156 to 1713 557 to 1       557/557
(100 %)
4 diff
(99.3 %id)
BE551328 carcinoid, lung .c 1158 to 1717 560 to 1       560/560
(100 %)
5 diff
(99.2 %id)
BM682974 eye, fetal eye .c 1164 to 1714 570 to 19   fully sequenced, AAA   552/552
(100 %)
1 diff
(99.9 %id)
AA453958   .c 1170 to 1394 1 to 225   fully sequenced,   225/225
(100 %)
0 diff
(100 %id)
AI223225   .c 1182 to 1721 539 to 1       539/539
(100 %)
6 diff
(98.9 %id)
AV750417 Pituitary .c 1205 to 1541 1 to 329       329/329
(100 %)
6 diff
(98.2 %id)
BP392222 pancreatic islet .c 1222 to 1714 7 to 499     Submitted on the opposite strand 493/499
(98 %)
0 diff
(100 %id)
T79601 liver and spleen .c 1222 to 1716 509 to 1       509/518
(98 %)
15 diff
(97.2 %id)
AA778335 heart .c 1224 to 1716 494 to 1       494/494
(100 %)
1 diff
(99.8 %id)
FN112250 breast carcinoma .c 1225 to 1328 1 to 104       104/111
(93 %)
6 diff
(94.6 %id)
BG219977   .c 1226 to 1714 8 to 496   AAA   489/496
(98 %)
6 diff
(98.8 %id)
AI140457 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1236 to 1714 502 to 24   AAA   479/479
(100 %)
3 diff
(99.4 %id)
AI127219 heart .c 1236 to 1717 482 to 1       482/482
(100 %)
4 diff
(99.2 %id)
AI131101 heart .c 1236 to 1714 479 to 1       479/479
(100 %)
0 diff
(100 %id)
BE157548 head_neck .c 1253 to 1431 32 to 202       171/202
(84 %)
6 diff
(97.1 %id)
BM719563 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1253 to 1742 1 to 490   AAA   490/490
(100 %)
0 diff
(100 %id)
BE157540 head_neck .c 1258 to 1438 208 to 28     Submitted on the opposite strand 181/208
(87 %)
0 diff
(100 %id)
AI128477 uterus .c 1261 to 1717 458 to 2       457/458
(99 %)
0 diff
(100 %id)
BG179631 adenocarcinoma, cell line, Prostate .c 1272 to 1714 97 to 531   AAA   435/531
(81 %)
6 diff
(98.9 %id)
AI308249 2 pooled tumors (clear cell type), Kidney .c 1277 to 1722 446 to 2       445/446
(99 %)
0 diff
(100 %id)
W94870 heart .c 1278 to 1715 439 to 1       439/442
(99 %)
6 diff
(98.7 %id)
AI291495 placenta .c 1283 to 1714 447 to 16   AAA   432/432
(100 %)
0 diff
(100 %id)
W95982 heart .c 1285 to 1706 1 to 423   fully sequenced,   423/423
(100 %)
2 diff
(99.6 %id)
AI086809 senescent fibroblast .c 1286 to 1714 447 to 19   AAA   429/429
(100 %)
0 diff
(100 %id)
AI143131 heart .c 1291 to 1717 427 to 1       427/427
(100 %)
0 diff
(100 %id)
DB508465 testis .c 1294 to 1714 1 to 420     Submitted on the opposite strand 420/420
(100 %)
1 diff
(99.8 %id)
AA340311 brain .c 1296 to 1714 1 to 424       424/424
(100 %)
6 diff
(98.6 %id)
FN101862 breast carcinoma .c 1296 to 1379 1 to 81       81/81
(100 %)
3 diff
(96.3 %id)
AI927383 normal prostate, Prostate .c 1298 to 1714 436 to 19   AAA   418/418
(100 %)
8 diff
(98.1 %id)
BU531898 mixed (pool of 40 RNAs) .c 1303 to 1717 1 to 415       415/925
(44 %)
2 diff
(99.8 %id)
AI351197 pooled germ cell tumors .c 1312 to 1738 452 to 26   AAA   427/427
(100 %)
0 diff
(100 %id)
FN049181 breast carcinoma .c 1314 to 1367 54 to 1     Submitted on the opposite strand 54/55
(98 %)
0 diff
(100 %id)
AI378207 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1315 to 1658 380 to 38       343/380
(90 %)
0 diff
(100 %id)
AA252526 germinal center B cell .c 1316 to 1714 399 to 1       399/399
(100 %)
0 diff
(100 %id)
AA399649.
matches multiple genes
  .c 1317 to 1714 414 to 18   AAA also hits gene glupla 397/397
(100 %)
2 diff
(99.5 %id)
AI377847 pooled .c 1321 to 1717 398 to 2       397/398
(99 %)
0 diff
(100 %id)
AI277363 placenta .c 1332 to 1714 399 to 17   AAA   383/383
(100 %)
1 diff
(99.8 %id)
DB510845 testis .c 1334 to 1714 1 to 381     Submitted on the opposite strand 381/381
(100 %)
5 diff
(98.7 %id)
AI880779 aorta .c 1334 to 1714 381 to 1       381/381
(100 %)
1 diff
(99.8 %id)
AI452626 pooled .c 1337 to 1717 384 to 4       381/384
(99 %)
0 diff
(100 %id)
CN363176 embryonic stem cells, DMSO-treated H9 cellline .c 1339 to 1741 1 to 404       404/404
(100 %)
1 diff
(99.8 %id)
W94655 heart .c 1350 to 1714 368 to 1   fully sequenced,   368/368
(100 %)
3 diff
(99.2 %id)
AI050906 parathyroid gland, parathyroid tumor .c 1354 to 1714 361 to 1       361/361
(100 %)
0 diff
(100 %id)
AA258841 germinal center B cell .c 1356 to 1714 359 to 1       359/359
(100 %)
0 diff
(100 %id)
AI094080 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1356 to 1714 379 to 21   AAA   359/359
(100 %)
0 diff
(100 %id)
AA453457   .c 1364 to 1717 354 to 1   fully sequenced,   354/354
(100 %)
0 diff
(100 %id)
DB512126 testis .c 1366 to 1714 67 to 415     Submitted on the opposite strand 349/415
(84 %)
6 diff
(98.6 %id)
BP351735   .c 1368 to 1718 1 to 350   AAA   350/350
(100 %)
1 diff
(99.8 %id)
AI248134 liver and spleen .c 1378 to 1714 337 to 1       337/337
(100 %)
0 diff
(100 %id)
BU508175 leiomyosarcoma, uterus .c 1385 to 1742 1 to 358   AAA   358/358
(100 %)
0 diff
(100 %id)
H87634 placenta .c 1394 to 1722 333 to 1       333/333
(100 %)
4 diff
(98.8 %id)
C02387   .c 1404 to 1714 1 to 312       312/312
(100 %)
1 diff
(99.7 %id)
AA687222 germinal center B cell .c 1404 to 1684 281 to 1       281/281
(100 %)
1 diff
(99.7 %id)
AA747544 germinal center B cell .c 1404 to 1738 354 to 20   AAA   335/335
(100 %)
0 diff
(100 %id)
AA826061 germinal center B cell .c 1404 to 1714 323 to 12   AAA   312/312
(100 %)
4 diff
(98.8 %id)
AW612967 colon, moderately-differentiated adenocarcinoma .c 1404 to 1671 268 to 1       268/268
(100 %)
0 diff
(100 %id)
AA568124   .c 1405 to 1647 1 to 243       243/243
(100 %)
2 diff
(99.2 %id)
AI473394 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1408 to 1719 312 to 1       312/312
(100 %)
1 diff
(99.7 %id)
H11507 whole brain .c 1410 to 1714 318 to 11   AAA   308/425
(72 %)
3 diff
(99.3 %id)
W94551 heart .c 1410 to 1714 305 to 1   fully sequenced,   305/305
(100 %)
0 diff
(100 %id)
AI783727 Prostate .c 1411 to 1698 310 to 23       288/310
(92 %)
0 diff
(100 %id)
H99056 melanocyte .c 1413 to 1705 299 to 1   fully sequenced,   299/299
(100 %)
1 diff
(99.7 %id)
AI783747 Prostate .c 1413 to 1700 290 to 3       288/290
(99 %)
0 diff
(100 %id)
AI758839 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 1417 to 1671 277 to 1       277/277
(100 %)
29 diff
(89.6 %id)
R56147 whole brain .c 1421 to 1738 345 to 22   AAA   324/326
(99 %)
7 diff
(97.9 %id)
AI440280 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1427 to 1671 245 to 1       245/245
(100 %)
1 diff
(99.6 %id)
FN105884 breast carcinoma .c 1434 to 1498 69 to 5     Submitted on the opposite strand 65/70
(92 %)
0 diff
(100 %id)
AA587631 colon, colon tumor RER+ .c 1434 to 1735 304 to 3       302/304
(99 %)
0 diff
(100 %id)
T32983 brain .c 1436 to 1714 279 to 1       279/279
(100 %)
0 diff
(100 %id)
TI_149301991   .c 1438 to 1738 366 to 66   AAA   301/967
(31 %)
0 diff
(100 %id)
BM980263 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1440 to 1738 317 to 19   AAA   299/299
(100 %)
0 diff
(100 %id)
AA648894 germinal center B cell .c 1448 to 1742 315 to 21   AAA   295/295
(100 %)
0 diff
(100 %id)
BU735828 eye, fetal eyes .c 1469 to 1714 264 to 19   AAA   246/246
(100 %)
1 diff
(99.6 %id)
AA976148 leiomyosarcoma, soft tissue .c 1470 to 1721 252 to 1       252/252
(100 %)
5 diff
(98.1 %id)
R50984 whole brain .c 1477 to 1714 253 to 16   AAA   238/238
(100 %)
0 diff
(100 %id)
AI758592 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 1494 to 1671 178 to 1       178/178
(100 %)
0 diff
(100 %id)
BQ012261 placenta .c 1496 to 1714 237 to 19   AAA   219/219
(100 %)
4 diff
(98.2 %id)
AA836078 germinal center B cell .c 1513 to 1738 236 to 11   AAA   226/226
(100 %)
0 diff
(100 %id)
T25933   .c 1537 to 1693 156 to 1       156/183
(85 %)
5 diff
(97.3 %id)
AA731324 germinal center B cell .c 1542 to 1714 192 to 20   AAA   173/173
(100 %)
0 diff
(100 %id)
AA909604 pooled .c 1543 to 1717 176 to 2       175/176
(99 %)
0 diff
(100 %id)
AA743519 germinal center B cell .c 1554 to 1714 197 to 37   AAA   161/161
(100 %)
0 diff
(100 %id)
FN121685 breast carcinoma .c 1557 to 1670 1 to 111       111/111
(100 %)
3 diff
(97.3 %id)
T16579   .c 1559 to 1714 156 to 1       156/156
(100 %)
1 diff
(99.4 %id)
AI291768 carcinoid, lung .c 1610 to 1743 136 to 3       134/136
(98 %)
0 diff
(100 %id)
FN075170 breast carcinoma .c 1618 to 1712 1 to 95       95/99
(95 %)
1 diff
(99.0 %id)
DA613257   .d 1 to 579 2 to 580   tiling clone, capped   579/579
(100 %)
1 diff
(99.9 %id)
BG774992 carcinoma, cell line, Prostate .d 26 to 784 1 to 762   tiling clone, fully sequenced,   762/762
(100 %)
3 diff
(99.7 %id)
Z45013 brain, total brain .d 44 to 378 15 to 349       335/349
(95 %)
6 diff
(98.3 %id)
BG775736 carcinoma, cell line, Prostate .d 754 to 1524 768 to 1   tiling clone, fully sequenced,   768/768
(100 %)
3 diff
(99.7 %id)
Z40742 brain, total brain .d 1352 to 1572 221 to 1   tiling clone,   221/221
(100 %)
0 diff
(100 %id)
AK094238 cerebellum .e 1 to 2272 2 to 2272 exact tiling clone, available from FLJ,   2272/2272
(100 %)
3 diff
(99.9 %id)
DA057459 cerebellum .e 1 to 596 2 to 596   capped   595/595
(100 %)
3 diff
(99.5 %id)
DA038833   .e 613 to 1172 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
CD690475 normal nasopharynx .e 633 to 1259 26 to 652       627/652
(96 %)
11 diff
(98.4 %id)
BP225721   .e 643 to 1224 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
AU120774 whole embryo, mainly body .e 644 to 1331 2 to 689   capped   688/688
(100 %)
0 diff
(100 %id)
DB025368 testis .e 669 to 1069 150 to 550   capped   401/549
(73 %)
6 diff
(99.0 %id)
CD627544   .e 680 to 872 199 to 8       192/201
(95 %)
4 diff
(98.1 %id)
DB046123 testis .e 681 to 1257 2 to 580   capped   579/579
(100 %)
4 diff
(99.4 %id)
CD627545   .e 683 to 872 1 to 189       189/196
(96 %)
4 diff
(98.0 %id)
BG479948 choriocarcinoma, placenta .e 684 to 1433 1 to 763       763/1061
(71 %)
37 diff
(96.6 %id)
BQ058096 lymph, lymphoma, cell line .e 687 to 1584 1 to 899       899/1014
(88 %)
11 diff
(99.0 %id)
BQ063808 lymph, lymphoma, cell line .e 687 to 1626 1 to 945       945/1020
(92 %)
14 diff
(98.7 %id)
BQ066000 lymph, lymphoma, cell line .e 687 to 1664 1 to 980       980/1009
(97 %)
19 diff
(98.2 %id)
BQ066378 lymph, lymphoma, cell line .e 687 to 1624 1 to 945       945/949
(99 %)
15 diff
(98.5 %id)
DA903677   .e 713 to 1277 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA063290 cerebellum .e 717 to 1281 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
BP195506 brain .e 718 to 1300 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DA343241 substantia nigra .e 719 to 1135 2 to 418   capped   417/417
(100 %)
0 diff
(100 %id)
BM843444 lymph node, stomach .e 721 to 1231 1 to 511       511/511
(100 %)
1 diff
(99.9 %id)
CB129315 cervix, Uterine .e 722 to 1326 1 to 605       605/605
(100 %)
0 diff
(100 %id)
DA083108 cerebellum .e 723 to 1200 2 to 479   capped   478/478
(100 %)
1 diff
(99.8 %id)
DA581420 lung .e 724 to 1295 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
BP261275 small intestine .e 724 to 1305 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP291601 lung .e 724 to 1276 1 to 554       554/556
(99 %)
14 diff
(97.5 %id)
DA135295 alzheimer cortex .e 725 to 1273 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DA427003 colon .e 725 to 1280 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DB024884 testis .e 725 to 1282 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DB038306 testis .e 725 to 1299 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DB048012 testis .e 725 to 1261 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
DB048297 testis .e 725 to 1282 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DB057830 testis .e 725 to 1262 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
DA268460 caudate nucleus .e 727 to 1291 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA065602 cerebellum .e 730 to 1293 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BI602627 brain, hypothalamus .e 730 to 1576 1 to 847       847/847
(100 %)
25 diff
(97.1 %id)
DB023212 testis .e 731 to 1286 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
TI_45213551   .e 735 to 1576 96 to 937       842/937
(89 %)
25 diff
(97.4 %id)
DB488380 hypothalamus .e 738 to 1187 1 to 451       451/459
(98 %)
2 diff
(99.6 %id)
BM555317 duodenal adenocarcinoma, cell line, small intestine .e 741 to 1049 13 to 322       310/1310
(23 %)
8 diff
(99.4 %id)
CN363177 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 742 to 1466 1 to 725       725/725
(100 %)
4 diff
(99.5 %id)
BF795069 lymph, lymphoma, cell line .e 742 to 1342 28 to 637       610/1012
(60 %)
22 diff
(97.9 %id)
BP302229   .e 744 to 1326 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP309014 brain .e 744 to 1324 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BU177867 melanotic melanoma, skin .e 745 to 1554 24 to 837       814/847
(96 %)
10 diff
(98.9 %id)
DA365428 subthalamic nucleus .e 746 to 1293 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
BI599466 brain, hypothalamus .e 747 to 1446 1 to 701       701/701
(100 %)
9 diff
(98.8 %id)
CB998990 Pooled-Skin .e 751 to 1501 1 to 753       753/815
(92 %)
19 diff
(97.7 %id)
BP209864 cerebellum .e 752 to 1331 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
DB443525 testis .e 752 to 1209 1 to 458       458/458
(100 %)
1 diff
(99.8 %id)
DB446974 testis .e 752 to 1183 1 to 433       433/435
(99 %)
2 diff
(99.6 %id)
TI_45211596   .e 752 to 1446 90 to 785       696/785
(88 %)
10 diff
(98.8 %id)
DA558558   .e 753 to 1298 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA606737   .e 753 to 1372 2 to 621   capped   620/622
(99 %)
1 diff
(99.9 %id)
CB107166 Liver .e 753 to 1177 1 to 425       425/425
(100 %)
1 diff
(99.8 %id)
DA829330 placenta .e 753 to 1537 2 to 791   capped   790/857
(92 %)
6 diff
(99.3 %id)
AU135775 placenta .e 753 to 1576 2 to 833   capped   832/838
(99 %)
16 diff
(98.1 %id)
DB046983 testis .e 753 to 1303 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
BP199091 brain .e 754 to 1337 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BP209436 cerebellum .e 754 to 1335 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP249572 Kidney .e 754 to 1336 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP275127 Kidney .e 754 to 1338 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
BP310195 brain .e 754 to 1330 1 to 577       577/582
(99 %)
4 diff
(99.4 %id)
BM790711 stomach .e 754 to 1415 1 to 662       662/662
(100 %)
0 diff
(100 %id)
BM855995 stomach .e 754 to 1008 1 to 255       255/255
(100 %)
2 diff
(99.3 %id)
BM856359 stomach .e 754 to 1419 1 to 666       666/666
(100 %)
0 diff
(100 %id)
BM857216 stomach .e 754 to 1221 1 to 468       468/468
(100 %)
0 diff
(100 %id)
DA063370 cerebellum .e 755 to 1314 2 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
DA064868 cerebellum .e 755 to 1319 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA076257 cerebellum .e 755 to 1325 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA077971 cerebellum .e 755 to 1317 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA123893 cerebellum .e 755 to 1309 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
DA362546 subthalamic nucleus .e 755 to 1310 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA367985 subthalamic nucleus .e 755 to 1303 2 to 550   capped   549/550
(99 %)
1 diff
(99.9 %id)
DA368562 subthalamic nucleus .e 755 to 1318 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA369155 subthalamic nucleus .e 755 to 1317 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA563489 heart .e 755 to 1324 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DA567320 heart .e 755 to 1315 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA930913 small intestine .e 755 to 1324 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB009637 colon, tumor tissue .e 755 to 1315 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB020378 testis .e 755 to 1323 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
AU142842   .e 755 to 1625 2 to 867   capped   866/866
(100 %)
7 diff
(99.2 %id)
BP264854 muscle .e 756 to 1386 1 to 632       632/644
(98 %)
5 diff
(99.3 %id)
BP208859 cerebellum .e 758 to 1338 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
DR159620 human embryonic stem cells differentiated toan early endodermal cell type .e 758 to 1568 1 to 811       811/811
(100 %)
1 diff
(99.9 %id)
BM753930 stomach .e 758 to 1253 1 to 497       497/497
(100 %)
2 diff
(99.6 %id)
DA001782   .e 759 to 1329 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA090616 cerebellum .e 759 to 1336 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
CD556352 brain, Pituitary .e 759 to 1344 52 to 639       588/1060
(55 %)
15 diff
(98.6 %id)
DB037660 testis .e 759 to 1333 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB049733 testis .e 759 to 1322 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BP193397 brain .e 760 to 1342 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA363301 subthalamic nucleus .e 760 to 1309 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
CD698971 normal nasopharynx .e 760 to 1118 17 to 375       359/375
(95 %)
7 diff
(98.2 %id)
BP245760 Kidney .e 760 to 1343 1 to 583       583/583
(100 %)
11 diff
(98.2 %id)
BG619269 placenta .e 760 to 1556 1 to 801       801/801
(100 %)
15 diff
(98.2 %id)
BU156565 melanotic melanoma, skin .e 760 to 1548 1 to 794       794/917
(86 %)
18 diff
(98.1 %id)
BU178917 melanotic melanoma, skin .e 760 to 1499 1 to 741       741/832
(89 %)
16 diff
(98.1 %id)
BU941481 mixed (pool of 40 RNAs) .e 760 to 1549 1 to 796       796/796
(100 %)
16 diff
(98.0 %id)
BP208303 cerebellum .e 761 to 1344 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
CD684975 normal nasopharynx .e 761 to 1314 31 to 584       554/584
(94 %)
6 diff
(99.0 %id)
CD704157 normal nasopharynx .e 761 to 1290 23 to 553       531/553
(96 %)
11 diff
(98.1 %id)
DB445820 testis .e 761 to 1204 1 to 441       441/441
(100 %)
4 diff
(99.1 %id)
BP260158 heart .e 761 to 1344 1 to 583       583/584
(99 %)
13 diff
(97.8 %id)
BM010956 brain, neuroblastoma, cell line .e 761 to 1470 1 to 726       726/866
(83 %)
28 diff
(96.8 %id)
CB999559 Pooled-Skin .e 761 to 1521 1 to 764       764/764
(100 %)
10 diff
(98.7 %id)
TI_59379845   .e 761 to 1470 102 to 827       726/866
(83 %)
28 diff
(96.8 %id)
DA897489 skeletal muscle .e 761 to 1312 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA429917 colon .e 762 to 1328 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA821230 pericardium .e 762 to 1336 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA892915 skeletal muscle .e 762 to 1576 2 to 814   capped   813/813
(100 %)
10 diff
(98.8 %id)
DB043732 testis .e 762 to 1338 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
DA823166 pericardium .e 763 to 1293 2 to 532   capped   531/531
(100 %)
1 diff
(99.9 %id)
DN993078 brain, whole brain .e 764 to 1447 1 to 684       684/684
(100 %)
6 diff
(99.2 %id)
BP378879 uterus .e 765 to 1348 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BI549776 brain, hippocampus .e 766 to 1523 8 to 766       759/766
(99 %)
9 diff
(98.9 %id)
BU595216 mixed (pool of 40 RNAs) .e 766 to 1590 1 to 827       827/828
(99 %)
29 diff
(96.5 %id)
TI_44171245   .e 766 to 1523 97 to 855       759/855
(88 %)
9 diff
(99.0 %id)
BP259243 heart .e 767 to 1330 1 to 564       564/564
(100 %)
3 diff
(99.5 %id)
BG258039 embryonal carcinoma, cell line, testis .e 767 to 1364 1 to 597       597/597
(100 %)
3 diff
(99.5 %id)
CD104423 Pooled-Skin .e 767 to 1406 1 to 640       640/656
(97 %)
3 diff
(99.6 %id)
TI_57175513   .e 768 to 1374 22 to 634       613/636
(96 %)
14 diff
(97.8 %id)
CD688738 normal nasopharynx .e 769 to 1265 15 to 512       498/512
(97 %)
12 diff
(97.7 %id)
CN363173 embryonic stem cells, DMSO-treated H9 cellline .e 769 to 1413 9 to 653       645/653
(98 %)
6 diff
(99.1 %id)
BX437094 thymus .e 769 to 1647 1 to 877       877/881
(99 %)
37 diff
(95.9 %id)
AL712493 human skeletal muscle .e 769 to 1371 10 to 612       603/603
(100 %)
0 diff
(100 %id)
BP321801 Pancreas .e 769 to 1349 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
DA368183 subthalamic nucleus .e 770 to 1339 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
AL709835 human skeletal muscle .e 770 to 1525 1 to 758       758/758
(100 %)
4 diff
(99.5 %id)
DA560371 heart .e 770 to 1238 2 to 471   capped   470/470
(100 %)
4 diff
(99.2 %id)
BG255484 adenocarcinoma, cell line, Prostate .e 770 to 1336 1 to 567       567/797
(71 %)
21 diff
(97.4 %id)
BI908438 leukocyte .e 770 to 1576 1 to 808       808/811
(99 %)
3 diff
(99.7 %id)
TI_57235466   .e 770 to 1576 30 to 837       808/840
(96 %)
14 diff
(98.4 %id)
CB131718 cervix, Uterine .e 771 to 1371 15 to 615       601/601
(100 %)
0 diff
(100 %id)
BP341048 stomach mucosa .e 771 to 1344 1 to 573       573/573
(100 %)
1 diff
(99.9 %id)
AV733483 pheochromocytoma .e 773 to 1373 1 to 601       601/646
(93 %)
3 diff
(99.6 %id)
BI831904 brain, medulla .e 773 to 1374 1 to 607       607/609
(99 %)
7 diff
(98.9 %id)
BQ940877 brain, neuroblastoma, cell line .e 773 to 1593 23 to 850       828/968
(85 %)
17 diff
(98.3 %id)
AA046504 uterus .e 774 to 1085 1 to 312       312/326
(95 %)
5 diff
(98.5 %id)
BM463435 embryonal carcinoma, cell line, testis .e 774 to 1779 1 to 1008       1008/1010
(99 %)
13 diff
(98.8 %id)
BQ071584 brain, neuroblastoma, cell line .e 774 to 1664 1 to 893       893/1016
(87 %)
18 diff
(98.3 %id)
BQ882947 brain, neuroblastoma, cell line .e 774 to 1441 1 to 673   AAA   673/838
(80 %)
19 diff
(97.8 %id)
BQ898982 brain, neuroblastoma, cell line .e 774 to 1665 1 to 890       890/891
(99 %)
8 diff
(99.2 %id)
BQ935603 large cell carcinoma, lung .e 774 to 1665 1 to 908       908/970
(93 %)
19 diff
(98.1 %id)
CX753532 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 774 to 1499 1 to 726     Submitted on the opposite strand 726/742
(97 %)
79 diff
(89.4 %id)
CD300326 testis .e 774 to 1590 1 to 820       820/828
(99 %)
4 diff
(99.6 %id)
BF309238 muscle, rhabdomyosarcoma .e 775 to 1399 1 to 621       621/621
(100 %)
11 diff
(98.3 %id)
BQ213874 embryonal carcinoma, cell line, testis .e 775 to 1485 1 to 715       715/911
(78 %)
30 diff
(96.8 %id)
CX165249 human embryonic stem cells differentiated toan early endodermal cell type .e 775 to 1597 1 to 823       823/823
(100 %)
0 diff
(100 %id)
DR759861 embryonic stem .e 775 to 1593 1 to 819       819/819
(100 %)
0 diff
(100 %id)
BG106603 lymph, lymphoma, cell line .e 777 to 1539 1 to 762       762/853
(89 %)
17 diff
(98.1 %id)
BX336714 Placenta Cot 25-normalized .e 778 to 1772 1 to 989       989/989
(100 %)
6 diff
(99.4 %id)
BX366150 Placenta Cot 25-normalized .e 778 to 1630 1 to 854       854/854
(100 %)
13 diff
(98.5 %id)
CV026360 mixed .e 778 to 1381 1 to 604       604/604
(100 %)
0 diff
(100 %id)
BE293024 adenocarcinoma cell line, colon .e 778 to 1422 1 to 641       641/644
(99 %)
11 diff
(98.3 %id)
BG258899 embryonal carcinoma, cell line, testis .e 778 to 1153 1 to 377       377/1005
(37 %)
5 diff
(99.6 %id)
CN363170 embryonic stem cells, DMSO-treated H9 cellline .e 779 to 1533 1 to 755       755/755
(100 %)
0 diff
(100 %id)
BM044354 carcinoma, cell line, Prostate .e 779 to 1544 1 to 778       778/778
(100 %)
32 diff
(95.9 %id)
BU171819 melanotic melanoma, skin .e 779 to 1655 1 to 877       877/877
(100 %)
6 diff
(99.4 %id)
T32984 brain .e 779 to 1077 1 to 298       298/298
(100 %)
4 diff
(98.7 %id)
BX464802 neuroblastoma .e 781 to 1770 1 to 983       983/984
(99 %)
17 diff
(98.3 %id)
BX464904 neuroblastoma .e 781 to 1636 1 to 854       854/854
(100 %)
9 diff
(99.0 %id)
AA085314   .e 781 to 1107 1 to 333       333/416
(80 %)
8 diff
(98.1 %id)
BQ944100 carcinoma, cell line, Prostate .e 781 to 1704 1 to 925       925/926
(99 %)
16 diff
(98.3 %id)
BU541260 carcinoma, cell line, Prostate .e 781 to 1664 1 to 885       885/907
(97 %)
4 diff
(99.6 %id)
BE737175 adenocarcinoma, Pancreas .e 783 to 1543 34 to 784       753/977
(77 %)
19 diff
(98.1 %id)
BQ719815 sympathetic trunk .e 783 to 1664 1 to 888       888/915
(97 %)
28 diff
(97.0 %id)
BQ720805 sympathetic trunk .e 783 to 1665 1 to 884       884/890
(99 %)
8 diff
(99.2 %id)
BQ877010 epidermoid carcinoma, cell line, lung .e 783 to 1620 34 to 879       846/931
(90 %)
25 diff
(97.4 %id)
BQ881357 dorsal root ganglia .e 784 to 1351 1 to 567       567/797
(71 %)
12 diff
(98.5 %id)
BU848662 ovary, teratocarcinoma, cell line .e 788 to 1665 1 to 876       876/906
(96 %)
3 diff
(99.7 %id)
AA313920 colon .e 789 to 1055 1 to 267       267/267
(100 %)
0 diff
(100 %id)
BE266177 lung, small cell carcinoma .e 790 to 1343 1 to 554       554/554
(100 %)
5 diff
(99.1 %id)
BE743264 adenocarcinoma cell line, ovary .e 791 to 1531 1 to 738       738/748
(98 %)
5 diff
(99.4 %id)
BE614739 adenocarcinoma, Pancreas .e 794 to 1665 1 to 955       744/1206
(61 %)
89 diff
(92.7 %id)
BE897836 melanotic melanoma, skin .e 794 to 1482 1 to 690       690/969
(71 %)
10 diff
(99.0 %id)
R83208 breast .e 795 to 1131 14 to 353       340/353
(96 %)
10 diff
(97.2 %id)
BE252278 eye, retinoblastoma .e 795 to 1367 1 to 573       573/574
(99 %)
1 diff
(99.9 %id)
BF973239 leiomyosarcoma cell line, uterus .e 795 to 1502 1 to 712       712/1204
(59 %)
12 diff
(99.1 %id)
BG338960 leiomyosarcoma cell line, uterus .e 795 to 1624 1 to 845       845/1113
(75 %)
24 diff
(97.9 %id)
DN602264 human embryonic stem cells .e 795 to 1665 1 to 871       871/877
(99 %)
3 diff
(99.7 %id)
BE745549 adenocarcinoma cell line, ovary .e 797 to 1625 1 to 832       832/901
(92 %)
26 diff
(97.2 %id)
BP248154 Kidney .e 802 to 1381 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
CN363175 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 806 to 1567 1 to 762       762/762
(100 %)
3 diff
(99.7 %id)
CN363171 embryonic stem cells, DMSO-treated H9 cellline .e 812 to 1528 1 to 717       717/717
(100 %)
2 diff
(99.8 %id)
AU123798   .e 813 to 1493 2 to 682   capped   681/690
(98 %)
5 diff
(99.3 %id)
BF127666 leiomyosarcoma cell line, uterus .e 815 to 1418 1 to 606       606/872
(69 %)
10 diff
(98.9 %id)
CD676758 eye, Trabecular meshwork .e 826 to 1462 1 to 636       636/636
(100 %)
1 diff
(99.9 %id)
TI_57193450   .e 851 to 1700 48 to 893       846/853
(99 %)
7 diff
(99.2 %id)
BI862111 breast, mammary adenocarcinoma, cell line .e 852 to 1700 1 to 845       845/852
(99 %)
7 diff
(99.2 %id)
BM844163 lymph node, stomach .e 862 to 1170 1 to 309       309/309
(100 %)
7 diff
(97.8 %id)
AA397735   .e 874 to 1364 1 to 491       491/491
(100 %)
1 diff
(99.8 %id)
BE275234 melanotic melanoma, skin .e 876 to 1652 1 to 766       766/886
(86 %)
26 diff
(97.1 %id)
BE895023 melanotic melanoma, skin .e 893 to 1501 1 to 609       609/794
(76 %)
7 diff
(99.2 %id)
BM790192 stomach .e 893 to 1529 1 to 636       636/641
(99 %)
1 diff
(99.9 %id)
BQ083020 stomach .e 893 to 1371 1 to 479       479/479
(100 %)
0 diff
(100 %id)
BM823089 stomach .e 893 to 1169 1 to 277       277/277
(100 %)
0 diff
(100 %id)
BM821309 stomach .e 897 to 1489 1 to 593       593/593
(100 %)
1 diff
(99.9 %id)
T35898 blood, white blood cells .e 911 to 1174 1 to 264       264/264
(100 %)
0 diff
(100 %id)
BQ226587 melanotic melanoma, skin .e 928 to 1780 1 to 856       856/917
(93 %)
10 diff
(99.0 %id)
FN143793 breast carcinoma .e 954 to 1047 92 to 1     Submitted on the opposite strand 92/92
(100 %)
2 diff
(97.9 %id)
BE786771 large cell carcinoma, lung .e 954 to 1635 1 to 681       681/956
(71 %)
17 diff
(98.3 %id)
BE074520 breast .e 960 to 1289 342 to 13     Submitted on the opposite strand 330/348
(94 %)
0 diff
(100 %id)
BG423561 Kidney, renal cell adenocarcinoma .e 964 to 1629 1 to 678       675/974
(69 %)
37 diff
(96.3 %id)
FN124311 breast carcinoma .e 967 to 1058 1 to 93       93/93
(100 %)
1 diff
(99.0 %id)
CN363178 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 994 to 1647 1 to 654       654/655
(99 %)
1 diff
(99.9 %id)
FN124510 breast carcinoma .e 1003 to 1054 1 to 52       52/53
(98 %)
3 diff
(94.4 %id)
BE892051 melanotic melanoma, skin .e 1009 to 1740 1 to 732       732/797
(91 %)
20 diff
(97.5 %id)
AI372497   .e 1015 to 1414 1 to 408       408/408
(100 %)
14 diff
(96.6 %id)
BE389470 endometrium, adenocarcinoma cell line, uterus .e 1054 to 1665 1 to 614       616/622
(99 %)
9 diff
(98.6 %id)
BE389404 endometrium, adenocarcinoma cell line, uterus .e 1054 to 1729 1 to 665       667/690
(96 %)
20 diff
(97.2 %id)
AA383791 testis .e 1064 to 1307 1 to 244       244/244
(100 %)
1 diff
(99.6 %id)
AW956758   .e 1064 to 1660 1 to 598       598/603
(99 %)
17 diff
(97.2 %id)
FN134213 breast carcinoma .e 1066 to 1150 85 to 1     Submitted on the opposite strand 85/86
(98 %)
0 diff
(100 %id)
BM810866 amelanotic melanoma, cell line, skin .e 1085 to 1735 1 to 656       656/1154
(56 %)
12 diff
(99.0 %id)
BE296232 muscle, rhabdomyosarcoma .e 1100 to 1777 1 to 673       673/748
(89 %)
15 diff
(98.0 %id)
BE269728 Burkitt lymphoma, lymph .e 1100 to 1780 1 to 668       668/684
(97 %)
19 diff
(97.3 %id)
BE298130 muscle, rhabdomyosarcoma .e 1102 to 1734 1 to 624       624/724
(86 %)
21 diff
(97.1 %id)
BP393802 pancreatic islet .e 1144 to 1644 501 to 1       501/501
(100 %)
0 diff
(100 %id)
CD513338 brain, Pituitary .e 1155 to 1735 174 to 760       585/1099
(53 %)
30 diff
(97.3 %id)
CB146336 Liver .e 1170 to 1698 1 to 529       529/529
(100 %)
0 diff
(100 %id)
CF140065 CNCAP(3)T-225 cell line, Prostate .e 1210 to 1611 1 to 402       402/402
(100 %)
3 diff
(99.3 %id)
AA134596 uterus .e 1211 to 1563 1 to 357       357/358
(99 %)
8 diff
(97.8 %id)
FN065679 breast carcinoma .e 1237 to 1327 91 to 1     Submitted on the opposite strand 91/91
(100 %)
0 diff
(100 %id)
CN363174 embryonic stem cells, DMSO-treated H9 cellline .e 1240 to 1759 1 to 520       520/520
(100 %)
4 diff
(99.3 %id)
BM553748 amelanotic melanoma, cell line, skin .e 1271 to 1780 217 to 727       511/1143
(44 %)
12 diff
(99.0 %id)
FN120211 breast carcinoma .e 1276 to 1358 1 to 84       84/91
(92 %)
6 diff
(93.5 %id)
FN158169 breast carcinoma .e 1338 to 1424 88 to 1     Submitted on the opposite strand 88/89
(98 %)
3 diff
(96.7 %id)
FN121773 breast carcinoma .e 1401 to 1487 87 to 1     Submitted on the opposite strand 87/90
(96 %)
3 diff
(96.7 %id)
AA045449 uterus .e 1417 to 1514 1 to 99       99/99
(100 %)
1 diff
(99.0 %id)
FN047254 breast carcinoma .e 1528 to 1596 1 to 69       69/69
(100 %)
2 diff
(97.2 %id)
FN137393 breast carcinoma .e 1560 to 1647 90 to 6     Submitted on the opposite strand 85/90
(94 %)
0 diff
(100 %id)
BE549150 cervical carcinoma cell line, cervix .e 1579 to 2202 1 to 709       624/935
(66 %)
32 diff
(96.6 %id)
FN117704 breast carcinoma .e 1617 to 1694 76 to 1     Submitted on the opposite strand 76/84
(90 %)
1 diff
(98.9 %id)
FN139432 breast carcinoma .e 1723 to 1780 1 to 57       57/58
(98 %)
2 diff
(96.6 %id)
DB296703 cerebellum .e 1763 to 2272 510 to 1       510/510
(100 %)
0 diff
(100 %id)
AU156255 placenta .e 1778 to 2272 495 to 1       495/498
(99 %)
4 diff
(99.2 %id)
AU146748 whole embryo, mainly body .e 1782 to 2272 486 to 1       486/539
(90 %)
11 diff
(98.0 %id)
DB330840 skeletal muscle .e 1813 to 2272 462 to 1       462/470
(98 %)
13 diff
(97.3 %id)
AA134597 uterus .e 1823 to 2270 454 to 3       452/454
(99 %)
0 diff
(100 %id)
AU156275 placenta .e 1852 to 2272 419 to 1       419/421
(99 %)
4 diff
(99.1 %id)
DA059959 cerebellum .f 1 to 571 8 to 578 G24D tiling clone, capped   577/577
(100 %)
1 diff
(99.9 %id)
BE391808 endometrium, adenocarcinoma cell line, uterus .f 323 to 875 83 to 630   tiling clone,   548/630
(86 %)
6 diff
(99.1 %id)
BE439652 Trabecular meshwork .g 1 to 613 8 to 617 K31R E32N I33L Y34S H35L ... tiling clone,   617/617
(100 %)
3 diff
(99.6 %id)
AW020601 cochlea, ear .h 1 to 464 1 to 464 exact tiling clone,   464/464
(100 %)
4 diff
(99.2 %id)
DA959116 Spleen .i 1 to 557 2 to 559 R27L Q28S I29D L30P E31G ... tiling clone, capped   558/558
(100 %)
2 diff
(99.7 %id)
BG432741 Kidney .i 43 to 799 1 to 766 S16R G17R S18L H19S K20* tiling clone,   766/767
(99 %)
25 diff
(96.8 %id)
BF911522 uterus_tumor .i 283 to 787 511 to 7   tiling clone, Submitted on the opposite strand 505/511
(98 %)
0 diff
(100 %id)
BG703239 brain, hippocampus .j 1 to 840 1 to 834 A31S E32R Q33T L34I F40C ... tiling clone,   834/864
(96 %)
27 diff
(96.9 %id)
BG400179 Kidney .k-u 1 to 687 1 to 677 F46X Y50M A51L G52D F53S ... tiling clone,   677/866
(78 %)
20 diff
(97.7 %id)
BX641638   .l-u 1 to 554 1 to 554 exact tiling clone,   554/554
(100 %)
2 diff
(99.7 %id)
BQ773661 Chondrosarcoma Grade II, Left Pelvis .l-u 7 to 593 605 to 19 exact tiling clone, AAA   587/596
(98 %)
2 diff
(99.7 %id)
DB306694 caudate nucleus Gene COPS4, variant not shown         This clone was ignored    
DA261307 caudate nucleus Gene COPS4, variant not shown       capped This clone was ignored    
CD697760 normal nasopharynx Gene COPS4, variant not shown         Suspected internal deletion, this clone was ignored    
AV712366   Gene COPS4, variant not shown         Suspected internal deletion, this clone was ignored    
AV717858   Gene COPS4, variant not shown         Suspected internal deletion, this clone was ignored    
AI890259 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus Gene COPS4, variant not shown         Suspected internal deletion, this clone was ignored    
BM475898 eye, retinoblastoma Gene COPS4, variant not shown         This clone was ignored    
TI_1948126202   Gene COPS4, variant not shown         This clone was ignored    
TI_1948126203   Gene COPS4, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI